Synapticure

We deliver personalized medicine for neurodegenerative patients

Chicago, United States · Founded 2019

Headquarters
Chicago, Illinois
Employees
11–50
Founded
2019
Business Model
B2C
Last Round
Series ANov 2024
Rounds
2

About

Personalized virtual clinical care is finally here for neurodegenerative diseases like Alzheimer's and related Dementias (Cognitive), Parkinson's and Huntington's (Movement), and ALS (Movement). We provide a novel approach to care in these diseases, centering a patient and caregiver around a coordinator who quarterbacks patients through our full Multi-Disciplinary Care Resources to local aid, PT/OT and home health support. When you leave our clinic, it's not with a handful of paper referrals, but with our coordinators helping you book and find the best physicians, DME, trials, and even cheapest prescriptions. We are devoted to helping patients, from guidance on care and insurance to providing the full spectrum of investigational and clinical testing to improve outcomes. Synapticure was built by leading patient and caregiver advocates alongside leading clinicians, biotech executives and telemedicine executives to bring the neurodegenerative disease care and treatment experience into the 21st century, and is backed by the leading Venture funds and Angel investors in the remote health and life sciences space.

Summary

Synapticure is a Digital Health company based in Chicago, United States, founded in 2019. Its most recent funding was a Series A round in Nov 2024.

Tech & App Stack

4 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series ASeries ANov 2024

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Similar Companies